5'-Nucleotidase Activity and Arachidonate Metabolism in Doxorubicin Sensitive and Resistant P388 Cells
Author Information
Author(s): A. Ramul, D. Glaubiger, P. Soprey, G.H. Reaman, N. Feuerstein
Primary Institution: Hadassah University Hospital
Hypothesis
The study investigates the differences in 5'-nucleotidase activity and arachidonate metabolism between doxorubicin-sensitive and resistant P388 cells.
Conclusion
Doxorubicin-resistant P388 cells show increased 5'-nucleotidase activity and arachidonate metabolism compared to sensitive cells, but these differences do not contribute to drug resistance.
Supporting Evidence
- Doxorubicin-resistant cells had 10 times higher 5'-nucleotidase activity than sensitive cells.
- Resistant cells released 6-fold more PGE2 than sensitive cells.
- The increase in enzyme activity in resistant cells may not indicate higher differentiation.
Takeaway
This study found that resistant cancer cells have higher enzyme activity and metabolite release than sensitive ones, but this doesn't help them resist the drug.
Methodology
P388 murine leukemia cells were cultured, and 5'-nucleotidase activity, arachidonate metabolism, and adenosine uptake were measured.
Limitations
The study does not explore the long-term effects of drug treatment on enzyme activity.
Participant Demographics
P388 murine leukemia cells, including a subline resistant to doxorubicin.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website